ALO

Alpharma Challenges Support On Increased Volume - 09/23 - 01:20 PM ET

Alpharma Hits New High On Increased Volume - 09/12 - 03:26 PM ET

Alpharma Cites Positive Results From Trial Of Morphine-Based Painkiller Embeda - 09/10 - 07:53 AM ET

Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting - 09/09 - 03:35 PM ET

Alpharma says FDA accepts new drug application for Embeda capsules - 09/02 - 07:11 AM ET

Alpharma Announces Acceptance of the EMBEDA(TM) Capsule NDA Filing - 09/02 - 07:00 AM ET

Alpharma Closes At New High On Buyout Offer - 08/22 - 04:12 PM ET

Alpharma Climbs In Pre-Market On Buyout Offer - 08/22 - 08:25 AM ET

Alpharma, Inc. (ALO) - 08/08 - 07:10 AM ET

Alpharma Continues with a Sell - 08/08 - 07:10 AM ET

Alpharma Reaffirms - 07/30 - 01:13 PM ET

ALO: Q2 Earnings Call @ 08:30 ET Today [delayed] - 07/30 - 07:26 AM ET

Alpharma Reports Second Quarter 2008 Revenue Growth of 25% From Continuing Operations - 07/30 - 07:02 AM ET

Alpharma Announces Information for Second Quarter 2008 Conference Call - 07/23 - 10:59 AM ET

Alpharma shares rise; initiated with outperform rating at Leerink Swann - 07/16 - 02:28 PM ET

ALO touches 200-day moving average at 22.99 - 07/03 - 12:49 PM ET

ALO: Resubmits NDa for EMBEDA Capsules - 07/01 - 10:10 AM ET

Alpharma resubmits new drug application for Embeda to FDA - 06/30 - 05:05 PM ET

Alpharma Announces the Resubmission of a New Drug Application for EMBEDA(TM) Capsules - 06/30 - 04:52 PM ET

ALO: To Present At Jefferies Healthcare Conference @ 11:45 ET [delayed] - 06/25 - 10:23 AM ET

Page 1 of 8     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index